Organization Overview
Historical Acquisition Tree
Alternative names
Key: Pharmaron (6) Acquired (142)
2,3-butanedione monoxime (1 trial)
allopurinol (zyloprim) (1 trial)
belumosudil (Rezurock) (4 trials)
bempedoic acid (NEXLETOL) (1 trial)
berotralstat (Orladeyo) (3 trials)
budesonide (rhinocort) (2 trials)
cannabidiol (Epidiolex) (1 trial)
carbidopa (sinemet) (2 trials)
cryptosporidium parvum oocysts (1 trial)
darolutamide (Nubeqa) (1 trial)
dihydroergotamine (D.H.E. 45) (2 trials)
dolutegravir (tivicay) (1 trial)
drospirenone (Yasmin) (1 trial)
esomeprazole (nexium) (1 trial)
estetrol (NEXTSTELLIS) (2 trials)
ethinyl estradiol (Estinyl) (1 trial)
fluticasone (cutivate) (1 trial)
formoterol (foradil) (2 trials)
Hydroxymethylfurfural (1 trial)
iloperidone (fanapt) (1 trial)
iron sucrose (venofer) (1 trial)
itraconazole (sporanox) (1 trial)
lansoprazole (prevacid) (1 trial)
levodopa (larodopa) (2 trials)
mifepristone (mifeprex) (1 trial)
moxifloxacin (avelox) (1 trial)
nafamostat (ronastat) (1 trial)
olanzapine (zyprexa) (1 trial)
omeprazole (prilosec) (1 trial)
osimertinib (tagrisso) (2 trials)
oxycodone (oxycontin) (1 trial)
perampanel (fycompa) (1 trial)
polyribocytidylic acid (1 trial)
polyriboinosinic acid (1 trial)
prednisone (meticorten) (4 trials)
rabeprazole (pariet) (2 trials)
ranolazine (ranexa) (2 trials)
salmeterol (serevent) (1 trial)
sargramostim (leukine) (1 trial)
selumetinib (Koselugo) (1 trial)
sitagliptin (januvia) (1 trial)
ticagrelor (brilinta) (2 trials)
tiotropium (spiriva) (2 trials)
Campylobacter Infections (Phase 2)
Cholera (Phase 2)
Hemorrhage (Phase 1)
Pain, Postoperative (Phase 1)
Subarachnoid Hemorrhage (Phase 1)
Substance-Related Disorders (Phase 1)